生物技术巨头Moderna(MRNA.O)今日盘中股价狂泻近5.06%,引发市场哗然。据悉,这与特朗普政府有意撤销对Moderna开发禽流感疫苗的5.9亿美元资助合同有着密切关联。
卫生官员正重新评估该合作协议,此举可能是政府审查mRNA疫苗支出的一部分。事实上,该笔资金去年1月已被拨付Moderna,推进其mRNA流感疫苗研发。一旦资金被切断,Moderna的流感疫苗项目前景堪忧,公司长期发展也将受到重创。
分析师指出,这与新任卫生部长罗伯特·F·肯尼迪对新冠mRNA疫苗持怀疑态度不无关系。随着全球疫情好转,政府可能将资源转向其他领域。但此举无疑将重挫Moderna在mRNA领域的布局,动摇对其长期前景的信心。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.